HLB bioStep Co.,Ltd. (KOSDAQ:278650)
South Korea · Delayed Price · Currency is KRW 2,875.00
-180.00 (-5.89%)
At close: Oct 2, 2026
HLB bioStep Market Cap
HLB bioStep has a market cap or net worth of 49.46 billion as of October 2, 2026. Its market cap has decreased by -56.37% in one year.
Market Cap
49.46B
Enterprise Value
50.02B
Revenue
72.15B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,875.00
ChartMarket Cap Chart
Since November 27, 2019, HLB bioStep's market cap has decreased from 254.44B to 49.46B, a decrease of -80.56%. That is a compound annual growth rate of -21.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 49.46B | -59.73% |
| Dec 30, 2025 | 122.82B | -30.37% |
| Dec 30, 2024 | 176.39B | -27.37% |
| Dec 28, 2023 | 242.88B | -25.95% |
| Dec 29, 2022 | 327.97B | 49.60% |
| Dec 30, 2021 | 219.23B | 14.63% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 27, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Penetrium Bioscience | 412.92B |
| DreamCIS | 89.05B |
| P&K Skin Research Center | 47.28B |
| Kolmar BioTech | 38.46B |
| SLS BIO | 26.89B |
| C&R Research | 26.38B |
| DT&CRO CO. | 25.22B |
| Curachem | 12.65B |